ICPT
Intercept Pharmaceuticals, Inc.
ICPT
ICPT
Delisted
ICPT was delisted on the 7th of November, 2023.
163 hedge funds and large institutions have $1.74B invested in Intercept Pharmaceuticals, Inc. in 2018 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 56 increasing their positions, 47 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
19% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 47
11% more funds holding
Funds holding: 147 → 163 (+16)
Holders
163
Holding in Top 10
3
Calls
$98.4M
Puts
$66.6M
Top Buyers
| 1 | +$63.4M | |
| 2 | +$55.5M | |
| 3 | +$47.9M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$37.9M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$14.2M |
Top Sellers
| 1 | -$86.6M | |
| 2 | -$30.8M | |
| 3 | -$17.3M | |
| 4 |
SM
Senvest Management
New York
|
-$14.8M |
| 5 |
Millennium Management
New York
|
-$13.3M |